Report overview
CRISPR (clustered regularly interspaced short palindromic repeats) is a family of DNA sequences found within the genomes of prokaryotic organisms such as bacteria and archaea.These sequences are derived from DNA fragments from viruses that have previously infected the prokaryote and are used to detect and destroy DNA from similar viruses during subsequent infections. Hence these sequences play a key role in the antiviral defense system of prokaryotes.
This report aims to provide a comprehensive presentation of the global market for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)Technology. This report contains market size and forecasts of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)Technology in global, including the following market information:
Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)Technology Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)Technology market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Products Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)Technology include Thermo Fisher Scientific, Merck, GenScript, Integrated DNA Technologies, Horizon Discovery Group, Agilent Technologies, Cellecta, GeneCopoeia and New England Biolabs, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)Technology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)Technology Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)Technology Market Segment Percentages, by Type, 2022 (%)
Products
Services
Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)Technology Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)Technology Market Segment Percentages, by Application, 2022 (%)
Biomedical Applications
Agricultural Applications
Industrial Applications
Biological Research
Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)Technology Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)Technology Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)Technology revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)Technology revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher Scientific
Merck
GenScript
Integrated DNA Technologies
Horizon Discovery Group
Agilent Technologies
Cellecta
GeneCopoeia
New England Biolabs
Origene Technologies
Synthego Corporation
Toolgen
Outline of Major Chapters:
Chapter 1: Introduces the definition of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)Technology, market overview.
Chapter 2: Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)Technology market size in revenue.
Chapter 3: Detailed analysis of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)Technology company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)Technology in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
